Canandaigua National Corp’s Novartis NVS Stock Holding History

Canandaigua National Corp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$535K	Buy	5,899 +201	+4%	+$16.9K	0.09%	163
2022 Q3	$433K	Sell	5,698 -89	-2%	-$7.38K	0.08%	175
2022 Q2	$489K	Sell	5,787 -471	-8%	-$41.3K	0.09%	172
2022 Q1	$549K	Sell	6,258 -66	-1%	-$5.71K	0.08%	176
2021 Q4	$553K	Buy	6,324 +354	+6%	+$29.4K	0.08%	179
2021 Q3	$488K	Sell	5,970 -13	-0.2%	-$1.17K	0.08%	176
2021 Q2	$546K	Sell	5,983 -137	-2%	-$12.2K	0.09%	165
2021 Q1	$523K	Sell	6,120 -590	-9%	-$52.9K	0.09%	168
2020 Q4	$634K	Sell	6,710 -104	-2%	-$9.09K	0.11%	153
2020 Q3	$593K	Sell	6,814 -85	-1%	-$7.36K	0.1%	157
2020 Q2	$603K	Buy	+6,899	New	+$596K	0.11%	158

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canandaigua National Corp's NVS Position: Q4 2022 in Review

Canandaigua National Corp increased its Novartis (NVS) stake by 3.5% in Q4 2022, buying an estimated $16.9K and bringing the position to 5,899 shares worth $535K. The position accounts for 0.09% of the portfolio, ranked #163.

Canandaigua National Corp first reported a position in NVS in Q2 2020 and has held it in 11 quarters since. The position peaked at $634K in Q4 2020. 1,182 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

Canandaigua National Corp held 5,899 shares of Novartis worth $535K as of Q4 2022.
Canandaigua National Corp bought 201 Novartis shares in Q4 2022, an estimated $16.9K.
Novartis made up 0.09% of Canandaigua National Corp's portfolio in Q4 2022, its #163 holding.
Canandaigua National Corp first reported a position in Novartis in Q2 2020 and has held it in 11 quarters since.
Canandaigua National Corp's Novartis position peaked at $634K in Q4 2020.
1,182 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.